± HEALTH Background Artificial intelligence (AI) methods are increasingly used to strengthen policy evaluation in mana…± HEALTH Background Artificial intelligence (AI) applications in managed care pharmacy depend on semantically consiste…± HEALTH Prior authorization (PA) imposes substantial administrative burdens on clinicians, contributing to burnout, d…± HEALTH Cardiovascular diseases remain the leading cause of mortality and morbidity worldwide, with substantial impac…+ HEALTH Cardiovascular (CV) diseases remain the leading cause of mortality in women and often present as the first cl…± HEALTH Xenotransplantation represents a potential solution to the persistent global organ shortage, yet its clinical…− HEALTH Aim To compare the multidimensional performance of discharge instructions generated by generative AI (GPT-4)…+ OTHER Background Ensuring animal welfare in extensive sheep production systems remains challenging due to large gra…
TruaceTracing the truth around AITuesday, September 1, 2026
Subscribe
TRV-2026-0954Certified recordPeer-reviewed

[Breast arterial calcifications and cardiovascular risk in women]

Cardiovascular (CV) diseases remain the leading cause of mortality in women and often present as the first clinical manifestation, highlighting the limitations of current risk scores. In this context, breast arterial calcifications (BACs), incidentally detected on screening mammography, are emerging as a potential biomarker of systemic CV risk. This narrative review summarizes the most recent evidence (2023-2026) on the association between BACs and CV outcomes, including observational studies, prospective and re…

Health · G Space — documented gain · certified 2026-09-01 · v1 · article view · machine-readable

Current reading — gain

Artificial intelligence-based algorithms improve quantification of breast arterial calcifications detected on screening mammography and strengthen their prognostic value for cardiovascular risk in women.

What this doesn’t fix

No evidence demonstrates incremental prognostic value of BACs beyond guideline-recommended scores like SCORE2 and SCORE2-OP, and prospective integration studies are still needed.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0954, v1: “[Breast arterial calcifications and cardiovascular risk in women].” Truvace, 2026-09-01. /record/TRV-2026-0954 (accessed at citation time). sha256 3c1c6bffaba0d850…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv13c1c6bffaba0…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0954 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.